Overview

A Phase II Study of an Otic Formulation in Treating Peri-Operative Tube Otorrhea

Status:
Completed
Trial end date:
2009-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine if an otic formulation is safe and effective in treating peri-operative tube otorrhea.
Phase:
Phase 2
Details
Lead Sponsor:
Alcon Research
Treatments:
Fluoroquinolones
Moxifloxacin
Norgestimate, ethinyl estradiol drug combination
Pharmaceutical Solutions